GMP蛋白（大腸桿菌）契約製造市場：按產品類型、應用、生產方法、最終用戶和地區分類

GMP Protein (E. Coli) Contract Manufacturing Market, By Product Type, By Application, By Method, By End User, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，GMP 蛋白（大腸桿菌）契約製造市場規模將達到 20.5 億美元，到 2033 年將達到 47.8 億美元。預計從 2026 年到 2033 年，該市場將以 12.8% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	20.5億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	12.80%	2033年市場規模預測：	47.8億美元

根據蛋白質的特性，GMP蛋白（大腸桿菌）的生產過程是否包含動物性成分，取決於其具體情況。重組蛋白是由重組DNA編碼的蛋白質，這些DNA已被克隆到支持基因表現和傳訊RNA翻譯的系統中。利用重組DNA技術進行基因改造可以產生突變蛋白。在細菌中共表達的蛋白質不會發生磷酸化或糖基化等轉譯後修飾。已生產並作為藥物上市的重組蛋白包括優泌林（Humulin）、海馬曲普（Hematrope）、Avonex）、科吉尼特（Cogenete）和棕櫚酶（Palmozyme）。

市場動態

預計在預測期內，市場上新產品數量的不斷增加將推動全球GMP蛋白（大腸桿菌）契約製造市場的成長。例如，2022年6月，高品質生命科學研究試劑和服務供應商AMSBIO宣布推出其用於細胞治療應用的「Stem Fit Protein」系列重組蛋白。「Stem Fit Protein」系列重組蛋白在胚胎幹細胞（ES細胞）和誘導性多功能幹細胞（iPS細胞）分化為胰臟、心臟、腎臟、血液和免疫細胞的過程中發揮關鍵作用。此外，2021年9月，為生命科學研究提供抗體、免疫檢測試劑盒和重組蛋白的供應商Aviva Systems Biology宣布推出其面向生命科學家開展基礎研究和臨床前試驗的全新“Protein on Demand”半客製化GMP級重組蛋白產品組合。「按需蛋白質」產品組合涵蓋超過 30 萬種蛋白質類型，使研究團隊能夠快速利用小規模到中等規模的客製化蛋白質生產。

本研究的關鍵特徵

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究基於以下參數分析了全球 GMP 蛋白（大腸桿菌）契約製造市場的主要參與者：公司亮點、產品系列、關鍵亮點、財務績效和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊可以就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球 GMP 蛋白（大腸桿菌）契約製造市場報告針對該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球 GMP 蛋白（大腸桿菌）契約製造市場中使用的各種策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

Merck & Co., Inc
Thermo Fisher Scientific Inc.
Abcam plc
GenScript
Biomay AG
SOL GROUP
Proteintech Group, Inc.
Nordmark Pharma GmbH
Sino Biological, Inc.
Kaneka Eurogentec SA
Abnova Corporation
Eurofins Scientific
Arcline Investment Management LP.
Abgenex
Xpress Biologics
Avid Bioservices, Inc.
Bio-Techne
Northway BIoTech
Aldevron
Institut Merieux
PerkinElmer Inc.
Creative BioMart
Profacgen
ProBioGen AG
53Biologics
Leadgene Biomedical, Inc.
Ajinomoto Bio-Pharma
FUJIFILM Diosynth BIoTechnologies
Avioq, Inc
Biovian Oy
KBI Biopharma
GTP Bioways
QIAGEN
Suzhou Novoprotein Technology Co., Ltd
ACROBiosystems
Kactus
F. Hoffmann-La Roche Ltd.
Enzo Life Sciences, Inc.

第10章

調查方法
關於本公司

簡介目錄

Product Code: CMI5433

GMP Protein (E. Coli) Contract Manufacturing Market is estimated to be valued at USD 2.05 Bn in 2026 and is expected to reach USD 4.78 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2.05 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	12.80%	2033 Value Projection:	USD 4.78 Bn

GMP Protein (E. coli) may or may not be manufactured using animal-free processes depending on the characteristics of the protein. Recombinant Protein is a protein encoded by a gene recombinant DNA that has been cloned in a system that supports the expression of the gene and translation of messenger RNA. Modification of the gene by recombinant DNA technology can lead to the expression of a mutant protein. Proteins co-expressed in bacteria will not possess post-translational modifications, e.g. phosphorylation or glycosylation. Some of the recombinant proteins which were produced and commercialized in medications are Humulin, Hematrope, Avonex, Kogenate, Pulmozyme and others.

Market Dynamics

Increasing launches of products in the market is expected to drive the growth of the global GMP protein (E. coli) contract manufacturing market over the forecast period. For instance, in June 2022, AMSBIO, a provider of quality life science research reagents and services, announced the launch of its Stem Fit Protein range of recombinant proteins for cell therapy applications. The Stem Fit Protein range includes recombinant proteins that play key roles in differentiating Embryonic Stem (ES) and induced Pluripotent Cells (iPS) in the pancreas, heart, kidney, blood, and immune cells. Moreover, in September 2021, Aviva Systems Biology, a company providing antibodies, immunoassay kits, and recombinant proteins for life science research, announced the launch of its new Protein on Demand semi-custom GMP grade recombinant protein portfolio for life scientists conducting basic research and preclinical studies. The Protein on Demand portfolio of over 300,000 proteins allows rapid access to small- to mid-scale production of customized proteins for research teams.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global GMP protein (E. coli) contract manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck & Co., Inc., Thermo Fisher Scientific Inc., Abcam plc, GenScript, Biomay AG, SOL GROUP, Proteintech Group, Inc., Nordmark Pharma GmbH, Sino Biological, Inc., Sino Biological, Inc., Abnova Corporation, Eurofins Scientific, Arcline Investment Management LP, Abgenex, Xpress Biologics, Avid Bioservices Inc, Bio-Techne, Northway Biotech, Aldevron, Institut Merieux, PerkinElmer Inc., Creative BioMart, Profacgen, ProBioGen AG, 53Biologics, Leadgene Biomedical, Inc., Ajinomoto Bio-Pharma, FUJIFILM Diosynth Biotechnologies, Avioq, Inc, Biovian Oy, KBI Biopharma, GTP Bioways, QIAGEN, Suzhou Novoprotein Technology Co., Ltd., ACROBiosystems, Kactus, F. Hoffmann-La Roche Ltd., and Enzo Life Sciences, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global GMP protein (E. coli) contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP protein (E. coli) contract manufacturing market.

Market Segmentation

Global GMP Protein (E. coli) Contract Manufacturing Market, By Product Type
- Cytokines
- Growth Factors
- Enzymes
- DNA polymerase
- Protease
- Trypsin
- Nuclease
- Benzonase
- Cas9 Nucleases
- Others
- IVT Enzymes
- Others
- Hormones
- Antigens
- Others
Global GMP Protein (E. coli) Contract Manufacturing Market, By Application:
- Gene Therapy
- Cell Therapy
Global GMP Protein (E. coli) Contract Manufacturing Market, By Method:
- In-Vivo
- Ex-Vivo
Global GMP Protein (E. coli) Contract Manufacturing Market, By End User:
- Biotechnology and Pharmaceutical Companies
- Academic & Research Institutes
- Contract Research Organizations
- Others
Global GMP Protein (E. coli) Contract Manufacturing Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Key Players
- Merck & Co., Inc.,
- Thermo Fisher Scientific Inc.
- Abcam plc
- GenScript
- Biomay AG
- SOL GROUP
- Proteintech Group, Inc.
- Nordmark Pharma GmbH
- Sino Biological, Inc.
- Abnova Corporation
- Eurofins Scientific
- Arcline Investment Management LP
- Abgenex
- Xpress Biologics,
- Avid Bioservices Inc
- Bio-Techne,
- Northway Biotech

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Method
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
PEST Analysis
Porter's Analysis
Key Developments
Regulatory Scenario
Acquisition and Agreement Scenario
Brand Mapping

4. Global GMP Protein (E. coli) Contract Manufacturing Market, By Product Type, 2020 - 2033, (US$ Billion)

Overview
- Market Share Analysis, 2022 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
Cytokines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
Growth Factors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
Enzymes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
  - DNA polymerase
  - Protease
  - Trypsin
  - Nuclease
    - Benzonase
    - Cas9 Nucleases
    - Others
  - IVT Enzymes
  - Others
Hormones
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
Antigens
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)

5. Global GMP Protein (E. coli) Contract Manufacturing Market, By Application, 2020 - 2033, (US$ Billion)

Overview
- Market Share Analysis, 2022 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
Gene Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
Cell Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)

6. Global GMP Protein (E. coli) Contract Manufacturing Market, By Method, 2020 - 2033, (US$ Billion)

Overview
- Market Share Analysis, 2022 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
In-Vivo
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
Ex-Vivo
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)

7. Global GMP Protein (E. coli) Contract Manufacturing Market, By End User, 2020 - 2033, (US$ Billion)

Overview
- Market Share Analysis, 2022 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
Biotechnology and Pharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
Contract Research Organizations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)

8. Global GMP Protein (E. coli) Contract Manufacturing Market, By Region, 2020 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2022 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Merck & Co., Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abcam plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GenScript
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Biomay AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
SOL GROUP
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Proteintech Group, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Nordmark Pharma GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sino Biological, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Kaneka Eurogentec S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abnova Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Arcline Investment Management LP.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abgenex
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Xpress Biologics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Avid Bioservices, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bio-Techne
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Northway Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Aldevron
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Institut Merieux
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Creative BioMart
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Profacgen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ProBioGen AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
53Biologics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Leadgene Biomedical, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ajinomoto Bio-Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
FUJIFILM Diosynth Biotechnologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Avioq, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Biovian Oy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
KBI Biopharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GTP Bioways
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
QIAGEN
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Suzhou Novoprotein Technology Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ACROBiosystems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Kactus
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Enzo Life Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies